e-learning
resources
ERS Research Seminars
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Check point inhibitors in advanced non small cell cancer
M. Garassino (Milano, Italy)
Source:
ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Number:
5
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Garassino (Milano, Italy). Check point inhibitors in advanced non small cell cancer. ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Combination therapy in the era of immunotherapy
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
New pathways, new targets
Related content which might interest you:
Check point inhibitors in peri-operative non small cell lung cancer strategy
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017
Cyclooxygenase(COX)-2 is over-expressed in non small cell lung cancer (NSCLC) and is a potential target for treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 400s
Year: 2002
Non small cell lung cancer: options and outcome of treatment beyond second line
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020
Reflex testing is crucial for treatment decisions in advanced non small cell lung cancer (NSCLC)
Source: International Congress 2017 – Chinese Programme 2017
Year: 2017
Emerging prognostic biomarkers in non small cell lung cancer patients: Impact of treatment with nimesulide (COX-2 inhibitor) combined with chemotherapy
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Chemotherapy in advanced non small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 77s
Year: 2005
Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009
Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Small cell lung cancer in patients with elderly
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007
Systemic therapy. non small cell lung cancer stage I and II: treatment standards and new development
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
The delays due to patient‘s and doctors‘ in non- small cell lung cancer patients
Source: Annual Congress 2003 - Lung cancer management and prognosis
Year: 2003
Gefitinib in the non small cell lung cancer treatment: contribution to prolongation and quality of survival
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004
A case of pulmonary tuberculosis development after receiving immune check point inhibitor in an advanced non-small cell lung cancer
Source: International Congress 2019 – Lung cancer?
Year: 2019
Small cell lung cancer patients and their responses to treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 301s
Year: 2004
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
Source: Eur Respir J 2010; 35: 202-215
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept